|Articles|July 1, 2020
- Pharmaceutical Executive-07-01-2020
- Volume 40
- Issue 7
Pharmaceutical Executive, July 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Will COVID-19 Usher in a New Era in Pharma Marketing?about 6 years ago
Is Drug Production Heading Back to Europe From Abroad?about 6 years ago
Central Focus: Targeting Unmet Need in CNSabout 6 years ago
Will the Industry Rise to the Occasion?about 6 years ago
How Oncologists are Coping with COVID-19about 6 years ago
Virtual Hiring of the C-Suiteabout 6 years ago
Culture and Compliance: Building a Culture of Business Ethicsabout 6 years ago
Fauci: Industry Will ‘Walk Away’ From COVID Price Controlsabout 6 years ago
A Sustainable Response to COVID-19about 6 years ago
Enterprise Leadership: Is Compliance Ripe for Disruption?Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition
2
FDA Approves Moderna's mRNA-Based Flu Vaccine
3
Amazon Pharmacy Launches GLP-1 Delivery Service
4
Your Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026
5
